The Latest Breaking News from Vaccine

The ACT government will make flu vaccines free for concession card holders from Monday.

There are 231 people in hospitals across the country receiving treatment for the worst effects of the virus

Rachel Stephen-Smith said the decision had been made to create more equitable access to the flu shot.

With the approval of Corbevax as a booster dose, India will have a heterologous shot

With cases reported in a number of countries, human monkeypox infection is generating global interest and concern as an emerging infectious disease threat even in the midst of a slowly relenting COVID-19 pandemic.

In mid-June, the World Trade Organization (WTO) will meet to finish negotiations to waive certain sections of the agreement on Trade Related Intellectual Property Rights (TRIPS). However, it is not the TRIPS waiver originally proposed 18 months ago by member states South Africa and India, which would have allowed countries…

The COVID-19 cases in India have crossed the 4,000-mark for the second time in the past four days on Sunday, as the country logged 4,270 fresh infections in the past 24 hours, according to the Union Health Ministry.

HYDERABAD: Biological E Limited's Corbevax has emerged as India's first Covid-19 vaccine to receive approval as a heterologous booster dose for those aged 18 years and above, after six months of receiving the second dose of either Covaxin or Covishield.

Researchers in Toronto are conducting human trials of the vaccine

Clinical trial data is reported to have shown that the Corbevax booster dose provided significant enhancement in immune response and a good safety profile.

Fewer than half of eligible Americans have received a third COVID vaccine shot despite clear evidence of its benefit. That booster shot improves your odds of avoiding even mild omicron. So why haven’t more people gotten it?